Quantcast
Last updated on April 17, 2014 at 13:22 EDT

Latest Glycoproteins Stories

2013-05-08 12:28:56

IRVINE, Calif., May 8, 2013 /PRNewswire/ -- GeneTex, Inc., a leading manufacturer of antibodies and antibody-related reagents, is introducing a new mouse monoclonal antibody to the human Ten-Eleven Translocation 1 (TET1) protein. The discovery in 2009 (Tahiliani et al, 2009) that this enzyme can convert the DNA methylation mark 5-methylcytosine (5mC) to 5-hydroxymethylcytosine (5hmC) helped to usher in a new field of research in epigenetics. Since then, it has become clear that TET1 and its...

2013-05-05 23:02:03

ResearchMoz.us include new market research report "Immunoglobulins Market to 2019 - Demand in Primary Immunodeficiency (PI) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) potentially supplemented by approvals for Alzheimers disease" to its huge collection of research reports. Albany, NY (PRWEB) May 05, 2013 Researchmoz presents this most up-to-date research on Immunoglobulins Market to 2019 - Demand in Primary Immunodeficiency (PI) and Chronic Inflammatory Demyelinating...

2013-05-04 23:01:41

Diet Doc now offers patients nationwide a price match guarantee, solidifying its reputation as the most affordable hCG diet plan in America. Los Angeles, CA (PRWEB) May 04, 2013 Diet Doc not only offers the most advanced version of the popular hCG diet, the company now offers a price match guarantee, making its hCG diet the most effective and the most affordable hCG diet plan in America. Patients across the country now have the opportunity to shop outside of their immediate geographic...

2013-05-03 23:17:42

Diet Doc announces a new and modernized version of the original hCG diet that is designed to target and burn unhealthy and unsightly belly fat. San Antonio, TX (PRWEB) May 03, 2013 Diet Doc announces a newly modified and modernized version of the original hCG diet that was developed by Dr A.T.W. Simeons in the 1950s. In addition to promoting fast weight loss, Diet Doc's new modern version of the diet plan specifically targets areas of fat in the most stubborn and difficult to lose areas,...

2013-05-01 12:28:57

AUSTIN, Texas, May 1, 2013 /PRNewswire/ -- XBiotech announced today that John Simard, Chairman, President & Chief Executive Officer, will present at the UBS Global Healthcare Conference in New York, NY on Monday, May 20(th) at 1:30pm ET. The conference will take place at the Sheraton New York Hotel May 20-22, 2013. John Simard remarked "XBiotech is delighted to be invited by UBS to present at this prestigious venue. UBS is one of the greatest financial institutions in the world and we...

2013-04-24 23:03:22

Shedding even a few pounds can provide significant cardiovascular benefit, making every pound lost a positive step toward healthier living. Diet Doc provides improved hCG diet plans that offer all Americans the opportunity to enjoy a future of improved health. Chicago, IL (PRWEB) April 24, 2013 Obesity is simply defined as having too much body fat. The American Heart Association observes that 60-70% of Americans are overweight or obese, putting these persons at an increased risk for health...

2013-04-24 08:28:56

BREDA, The Netherlands and GHENT, Belgium, April 24, 2013 /PRNewswire/ -- First program based on proprietary ABDEG(TM) technology to promote degradation and clearance of disease-causing autoantibodies arGEN-X, a clinical stage biopharmaceutical company specialized in the discovery and development of highly differentiated human monoclonal antibody therapeutics, announces that it has progressed its second product candidate this year into formal preclinical development. Complementing its...

2013-04-22 04:21:10

CAMBRIDGE, England, April 22, 2013 /PRNewswire/ -- Kymab, a monoclonal antibody biopharmaceutical company, announced today an agreement in therapeutic antibody discovery. Novo Nordisk has been granted a non-exclusive licence to Kymab's proprietary Kymouse(TM) human antibody discovery platform to discover, develop and commercialise therapeutic monoclonal antibody drugs for human diseases. The licence provides Novo Nordisk with access to the Kymouse HK and Kymouse HL...

2013-04-17 23:00:13

Obesity is among one of the greatest challenges facing America today. Diet Doc provides patients with lifestyle changing diet plans to win the battle against weight-related illness, including gastrointestinal disorders. Houston, TX (PRWEB) April 17, 2013 The association between obesity and gastrointestinal-related cancers, and the link between an overweight or obese body mass index and the severity of Crohn's disease were among the highlights of new research that was presented at the...

2013-04-16 12:26:37

DUBLIN, Ireland, April 16, 2013 /PRNewswire/ -- Research and Markets announces the addition of "Antibody Technologies and Attrition Rates - an industry analysis 2013 [http://www.researchandmarkets.com/research/7rg77r/antibody ]" to its catalogue. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) The report Antibody Technologies and Attrition Rates - an industry analysis 2013 is based on the identification of the antibody generation technologies of 504...